Previous Close | 9.81 |
Open | 9.82 |
Bid | 9.75 x 3200 |
Ask | 9.76 x 1200 |
Day's Range | 9.63 - 9.89 |
52 Week Range | 4.80 - 18.04 |
Volume | |
Avg. Volume | 1,070,733 |
Market Cap | 522.05M |
Beta (5Y Monthly) | 1.36 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.69 |
Earnings Date | Feb 26, 2024 - Mar 01, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 10.80 |
The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in CareDx (CDNA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
The mean of analysts' price targets for CareDx (CDNA) points to a 29.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
CareDx, Inc (NASDAQ:CDNA) Q3 2023 Earnings Call Transcript November 8, 2023 CareDx, Inc beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.38. Operator: Good day, everyone, and welcome to today’s CareDx Inc. Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity […]